CME/CE

CME/CE

By ReachMDMedicine
Download on the App Store

CME/CE episodes

  • I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
    Guest: Naim Alkhouri, MD, FAASLD, DABOM
    Guest: Tessa Janovsky, PA-C

    This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.

    6 min
  • Treating Patients With T2D and MASLD: Is the Tide Changing?
    Guest: Naim Alkhouri, MD, FAASLD, DABOM

    This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.

    6 min
  • More Screening Recommendations? These Could Save Your Patient's Life
    Guest: Tessa Janovsky, PA-C

    This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.

    5 min
  • CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
    Host: Matthew Lunning, DO, FACP

    In the rapidly evolving landscape of treating patients with relapsed or refractory large/diffuse large B-cell lymphoma (R/R LBCL/DLBCL), recent advancements are providing newfound hope. Immunochemotherapy with R-CHOP has long been the standard first-line treatment, but a significant portion of patients experience relapses and refractory disease. Until recently, salvage chemotherapy followed by autologous stem cell transplant (ASCT) was the only curative option. However, the introduction of novel therapies including T-cell engaging therapies has sparked a paradigm shift in R/R LBCL/DLBCL management.

    In this transforming landscape, bispecific antibodies (BsAbs) stand out as a remarkable addition. They offer readily available, "off-the-shelf" options that do not require a manufacturing process tailored to each patient, with the advantage of lower rates of severe side effects compared to CAR T-cell therapy, making them a promising choice, particularly for older patients and those with late-stage disease.

    This web-based, on-demand activity highlights key clinical trial evidence for bispecific antibodies targeting CD20 and CD3, and how to contextualize the rationale for and clinical utility of integrating CD20 X CD3 bispecific antibodies into community-based clinical practice. Expert faculty offer insights and advice based on their own real-world clinical practice experiences regarding the management and treatment of R/R DLBCL/LBCL and appropriate …

    32 min
  • Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective
    Host: Natalie Kreitzer, MD, MS
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: Thorsten Steiner, MD, PhD, MME
    Host: Adrian R. Parry-Jones, FRCP, PhD

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    11 min
  • ESO Guidelines for the Management of ICH in the Anticoagulated Patient
    Host: Thorsten Steiner, MD, PhD, MME
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: David Seiffge, MD
    Host: Adrian R. Parry-Jones, FRCP, PhD
    Host: Natalie Kreitzer, MD, MS

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    13 min
  • Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE
    Host: Hiren C. Patel, PhD, FRCS
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: Adrian R. Parry-Jones, FRCP, PhD
    Host: Thorsten Steiner, MD, PhD, MME

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    14 min
  • Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
    Host: Adrian R. Parry-Jones, FRCP, PhD
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: Hiren C. Patel, PhD, FRCS
    Host: David Seiffge, MD

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    13 min

About CME/CE

From the publisher's feed

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes,…